Metastatic HER2 Negative Breast Adenocarcinoma
1 clinical trials · Condition
◉ Watch Metastatic HER2 Negative Breast Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial (NCT04756505) | M.D. Anderson Cancer Center | 2021-03-07 |
Track Metastatic HER2 Negative Breast Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.